Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.1950
+0.0220 (+12.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,091,197
Open
0.1800
Bid (Size)
0.1910 (17)
Ask (Size)
0.2000 (2)
Prev. Close
0.1730
Today's Range
0.1692 - 0.2029
52wk Range
0.0955 - 137.50
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
August 22, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
August 22, 2024
Via
ACCESSWIRE
Performance
YTD
-99.67%
-99.67%
1 Month
-81.94%
-81.94%
3 Month
-98.14%
-98.14%
6 Month
-98.54%
-98.54%
1 Year
-99.78%
-99.78%
More News
Read More
Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer
August 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
August 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024
August 15, 2024
Via
InvestorPlace
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
Via
ACCESSWIRE
What's Going On With CNS Pharmaceuticals Stock Tuesday?
July 30, 2024
Via
Benzinga
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
July 16, 2024
Via
ACCESSWIRE
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 06, 2024
Via
Benzinga
Study Uncovers How Brain Tumors Evolve During Treatment
August 05, 2024
Via
Investor Brand Network
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
August 05, 2024
Via
Benzinga
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue
July 30, 2024
Via
InvestorPlace
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis
July 30, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
July 30, 2024
Via
InvestorPlace
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
July 30, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Dow Jumps 200 Points; Pfizer Earnings Top Views
July 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
July 30, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CMO to Present Poster at Upcoming SNO/ASCO CNS Cancer Conference
July 25, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
July 25, 2024
Via
ACCESSWIRE
Study Uncovers Ancient Egyptian Attempts to Surgically Remove Brain Cancer
July 22, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
July 16, 2024
Via
Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 11, 2024
Via
InvestorPlace
Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
July 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
July 05, 2024
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.